83 results
8-K
EX-99.1
DMAC
DiaMedica Therapeutics Inc.
7 Aug 24
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results
4:32pm
.
Financial Results
Research and development (R&D) expenses increased to $3.9 million for the three months ended June 30, 2024, up from $2.5 million … expenses:
Research and development
General and administrative
Operating loss
Other income:
Other income, net
Loss before income tax expense
Income
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
23 May 24
Departure of Directors or Certain Officers
4:00pm
related to acquired in-process research and development; (o) items relating to changes in tax laws; (p) items relating to major licensing
8-K
EX-99.1
DMAC
DiaMedica Therapeutics Inc.
8 May 24
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
4:30pm
in the current year period.
Financial Results
Research and development (R&D) expenses increased to $3.7 million for the three months ended March 31 … )
Three Months Ended
March 31,
Operating expenses:
Research and development
General and administrative
Total operating expenses
Operating loss
Other
8-K
EX-99.1
76s32tmr6mojvjtj
19 Mar 24
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
4:16pm
8-K
EX-99.1
hkciw nie
13 Nov 23
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
4:52pm
8-K
EX-99.1
shqqd
14 Aug 23
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
4:25pm
8-K
EX-99.1
nzastypolvpwpgh426
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
8-K
EX-99.1
bfjq5
15 May 23
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results
4:31pm
8-K
EX-99.1
4rmwwm 08jdm
9 Nov 22
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
4:20pm
8-K
EX-99.1
6o12 yi9isxyl
10 Aug 22
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
5:22pm
8-K
yh9ktpvi
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm